Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Oct 27, 2014 at 10:30 AM EDT

Biotech Short Interest Becomes Stock Specific

Short interest in biotech leaders changed from directional to stock specific in the first two weeks of October.

Chris Lange | Oct 27, 2014 at 8:40 AM EDT

Merck Earnings Look Very Mixed in Major Restructuring

Merck reported better-than-expected third-quarter earnings Monday morning.

Chris Lange | Oct 24, 2014 at 10:15 AM EDT

Lakeland Private Placement Comes at Severe Discount to Ebola Trade

Lakeland Industries announced that it entered into a definitive securities purchase agreement to raise $11.2 million in a private placement…

Jon C. Ogg | Oct 24, 2014 at 8:05 AM EDT

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

Pfizer's new buyback is simply too large and too significant to ignore, and it might jokingly be called "on Viagra."

Jon C. Ogg | Oct 23, 2014 at 3:30 PM EDT

New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)

ThinkstockJust when you thought the Ebola virus outbreak risk was dwindling down… Fresh headlines from Dow Jones and the New…

Chris Lange | Oct 23, 2014 at 2:39 PM EDT

Will Celgene Become the Next $100 Billion Biotech Stock?

ThinkstockDoes Celgene Corporation (NASDAQ: CELG) have what it takes to make it to a $100 billion market cap? Some analysts…

Lee Jackson | Oct 23, 2014 at 9:15 AM EDT

Companies That Benefit as Sexually Transmitted Disease Cases Keep Growing

The following companies were featured in a new Leerink report on understand testing trends for sexually transmitted diseases.

Chris Lange | Oct 22, 2014 at 11:50 AM EDT

After Multiyear Turnaround, Is Boston Scientific Finally (and Really) Back?

24/7 Wall St. would ask if this turnaround in Boston Scientific earnings and outlook is really convincing investors.

Lee Jackson | Oct 22, 2014 at 10:05 AM EDT

3 Irish Specialty Pharmaceutical Stocks to Buy After Tax Inversion Implosion

A new research report from Merrill Lynch features three top pharmaceutical companies, dubbed the “Irish 3-Pack.”

Chris Lange | Oct 22, 2014 at 9:05 AM EDT

Biogen Takes Breather on Earnings and MS Drug Sales

Biogen Idec reported better-than-expected third-quarter results before the market opened Wednesday.

Jon C. Ogg | Oct 21, 2014 at 4:22 PM EDT

The Plan to Drive Amgen Shares Up Over 70%

Amgen Inc. (NASDAQ: AMGN) used to be the king of biotech by size. That was then, and now is the…

Chris Lange | Oct 21, 2014 at 3:08 PM EDT

Why Everyone Likes Illumina Again

ThinkstockIllumina Inc. (NASDAQ: ILMN) reported its earnings before the market opened Monday as $0.77 in earnings per share and $481…

Chris Lange | Oct 21, 2014 at 9:45 AM EDT

Connecture Files for IPO: Health Care Insurance Platform

Connecture Inc. has filed with the Securities and Exchange Commission to have an initial public offering.

Jon C. Ogg | Oct 20, 2014 at 1:30 PM EDT

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

Goldman Sachs has initiated on MannKind with a Neutral rating and a $6 price target, a move that may seem…

Jon C. Ogg | Oct 20, 2014 at 10:45 AM EDT

Ebola Stock Fallout Severe on Monday

Some of the Ebola high-flying stocks saw their share prices crater on Monday as Ebola fears are subsiding for several…

1 … 277 278 279 280 281 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Biotech Short Interest Becomes Stock Specific

Merck Earnings Look Very Mixed in Major Restructuring

Lakeland Private Placement Comes at Severe Discount to Ebola Trade

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)

Will Celgene Become the Next $100 Billion Biotech Stock?

Companies That Benefit as Sexually Transmitted Disease Cases Keep Growing

After Multiyear Turnaround, Is Boston Scientific Finally (and Really) Back?

3 Irish Specialty Pharmaceutical Stocks to Buy After Tax Inversion Implosion

Biogen Takes Breather on Earnings and MS Drug Sales

The Plan to Drive Amgen Shares Up Over 70%

Why Everyone Likes Illumina Again

Connecture Files for IPO: Health Care Insurance Platform

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

Ebola Stock Fallout Severe on Monday

Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

Apple Will Run Advanced AI Model on Nvidia GPUs via Google Cloud, Ditching Private Infrastructure

Will XRP Explode? The Rare RSI Signal That Preceded Every Major Rally Just Flashed Again

The Capex Signal That Will Make or Break IGPT in the Next 12 Months

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

74-Year-Old With $2.6M Discovers Late Husband's IRA RMD Doubled Her Tax Bill

Apple Will Run Advanced AI Model on Nvidia GPUs via Google Cloud, Ditching Private Infrastructure

Will XRP Explode? The Rare RSI Signal That Preceded Every Major Rally Just Flashed Again

Health and Healthcare Articles

All Health and Healthcare Articles

Biotech Short Interest Becomes Stock Specific

Merck Earnings Look Very Mixed in Major Restructuring

Lakeland Private Placement Comes at Severe Discount to Ebola Trade

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

New Ebola Fears in NYC Make Major Ebola Stock Waves (Updated)

Will Celgene Become the Next $100 Billion Biotech Stock?

Companies That Benefit as Sexually Transmitted Disease Cases Keep Growing

After Multiyear Turnaround, Is Boston Scientific Finally (and Really) Back?

3 Irish Specialty Pharmaceutical Stocks to Buy After Tax Inversion Implosion

Biogen Takes Breather on Earnings and MS Drug Sales

The Plan to Drive Amgen Shares Up Over 70%

Why Everyone Likes Illumina Again

Connecture Files for IPO: Health Care Insurance Platform

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

Ebola Stock Fallout Severe on Monday

Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

Apple Will Run Advanced AI Model on Nvidia GPUs via Google Cloud, Ditching Private Infrastructure

Will XRP Explode? The Rare RSI Signal That Preceded Every Major Rally Just Flashed Again

The Capex Signal That Will Make or Break IGPT in the Next 12 Months

Featured Reads

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

74-Year-Old With $2.6M Discovers Late Husband's IRA RMD Doubled Her Tax Bill